REG - JP Morgan Sec LLC Willis Towers Watson - Willis Towers Watson plc 8.3 AMEND

Willis Towers WatsonAnnouncement

10/06/2021 17:55

RNS Number : 5572B
  
J.P. Morgan Securities LLC
  
10 June 2021
  
 

Ap19
 
 
   AMENDMENT
FORM 8.3
 
IRISH TAKEOVER PANEL
 
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
 
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
 
1.       KEY INFORMATION
 




Name of person dealing (Note 1)


J.P. Morgan Securities LLC




Company dealt in


Willis Towers Watson plc




Class of relevant security to which the dealings being disclosed relate (Note 2)


US$0.000304635 ordinary shares




Date of dealing


25 May 2021




 
2.         INTERESTS AND SHORT POSITIONS
 
(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)




 


Long


Short




 


Number


 


(%)


Number


 


(%)




(1) Relevant securities


1,913,212                1.48
 


1,560,908             1.21
 




(2) Derivatives (other than options)


1,396,480                1.08
 


1,743,338                1.35
 




(3) Options and agreements to purchase/sell


              0.00
 


              0.00
 




Total


3,309,692             2.56
 


3,304,246             2.56
 



 
 
 
 
 
 
 



 

 

Ap20
 
 
1.       DEALINGS (Note 4)
 
(a)      Purchases and sales
 




 
Purchase/sale


 
Number of relevant securities


 
Price per unit (USD)
 
(Note 5)




Sale (Borrow Return)
 
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
Purchases
 
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales
Sales


200
 
27 
 7,902 
 145 
 2 
 44 
 578 
 400 
 36 
 3 
 3 
 4 
 25 
 200 
 48 
 175 
 12 
 193 
 53 
 14 
 100 
 12 
 6 
 13 
 200 
 4 
 4 
 
 10,328 
 100 
 94 
 1,506 
 104 
 100 
 100 
 199 
 2 
 2 
 1 
 200 
 193 
 1 
 2 
 1 
 48,194 
 4


N/A
 
261.5885     USD
261.5900     USD
261.6259     USD
261.6350     USD
261.6600     USD
261.6687     USD
261.7300     USD
261.7400     USD
261.7467     USD
261.7500     USD
261.7650     USD
261.7748     USD
261.8500     USD
261.8600     USD
261.8837     USD
261.8851     USD
261.8900     USD
261.9792     USD
261.9817     USD
262.0267     USD
262.4521     USD
262.7083     USD
262.8358     USD
262.9200     USD
263.8000     USD
263.8225     USD
                        
261.5900     USD
261.6000     USD
261.6300     USD
261.6423     USD
261.6674     USD
261.6700     USD
261.7000     USD
261.7246     USD
261.7480     USD
261.7550     USD
261.8100     USD
261.8500     USD
261.8900     USD
262.5300     USD
262.6550     USD
262.7900     USD
262.9200     USD
263.8225     USD




 
 
 
 
 
 
(b)      Derivatives transactions (other than options transactions)
 




Product name,
e.g. CFD


Nature of transaction
(Note 6)


Number of relevant securities
(Note 7)


Price per unit
(USD) (Note 5)




Equity Swap
 
 


Decrease Long


4


263.8237




 
 
(c)      Options transactions in respect of existing relevant securities
 
 
(i)       Writing, selling, purchasing or varying
 
 




Product name,
e.g. call option


Writing, selling, purchasing, varying etc.


Number of securities to which the option relates (Note 7)


Exercise price


Type, e.g. American, European etc.


Expiry date


Option money paid/received per unit (Note 5)




 


 


 


 


 


 


 




 
 
(ii)      Exercising
 




Product name,
e.g. call option


Number of securities


Exercise price per unit (Note 5)




 


 


 




 
 
(d)      Other dealings (including transactions in respect of new securities) (Note 4)
 




Nature of transaction
(Note 8)


Details


Price per unit
(if applicable) (Note 5)




 


 


 




 
                          
 
Ap21
 
2.       OTHER INFORMATION
 
Agreements, arrangements or understandings relating to options or derivatives
 
 
 
 
Full details of any agreement, arrangement or understanding between the person disclosing and any 
other person relating to the voting rights of any relevant securities under any option referred to on this 
form or relating to the voting rights or future acquisition or disposal of any relevant securities to which 
any derivative referred to on this form is referenced. If none, this should be stated.
 
     None
 
 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                                            NO
 




Date of disclosure


 10 June 2021




Contact name


Alwyn Basch




Telephone number


0207 742 7407




If a connected EFM, name of offeree/offeror with which connected


N/A




If a connected EFM, state nature of connection (Note 10)


N/A




 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
ISEURVNRARUNAAR